Louis P. Lacasse
Chairman at Centre For Commercialization of Cancer Immunotherapy
Louis P. Lacasse active positions
Companies | Position | Start | End |
---|---|---|---|
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Private Equity Investor | 2011-01-12 | - |
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Director/Board Member | - | - |
AgeChem Financial, Inc.
AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Director/Board Member | 1996-12-31 | - |
Corporate Officer/Principal | 2009-11-22 | 2013-08-18 | |
President | 2013-08-18 | - | |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Director/Board Member | - | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Chairman | - | - |
Career history of Louis P. Lacasse
Former positions of Louis P. Lacasse
Companies | Position | Start | End |
---|---|---|---|
HISTOGEN INC. | Director/Board Member | 2011-02-13 | 2016-06-22 |
Independent Dir/Board Member | 2011-01-31 | 2016-06-22 | |
CALYX VENTURES INC. | Director/Board Member | 2009-11-22 | 2013-10-15 |
Independent Dir/Board Member | 2008-06-09 | 2013-10-15 | |
WARNEX INC. | Director/Board Member | 2010-01-11 | 2013-04-28 |
Independent Dir/Board Member | 1997-12-31 | 2013-04-28 | |
MIRATI THERAPEUTICS | Director/Board Member | 2000-12-31 | 2012-11-11 |
Independent Dir/Board Member | 2012-02-26 | 2012-11-11 | |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░ ░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Louis P. Lacasse
McGill University | Masters Business Admin |
École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Statistics
International
Canada | 22 |
United States | 5 |
France | 2 |
Operational
Director/Board Member | 17 |
Corporate Officer/Principal | 5 |
Independent Dir/Board Member | 4 |
Sectoral
Health Technology | 15 |
Finance | 8 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
NATIONAL BANK OF CANADA | Finance |
BANK OF MONTREAL | Finance |
CALYX VENTURES INC. | Technology Services |
Private companies | 21 |
---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Advitech, Inc.
Advitech, Inc. BiotechnologyHealth Technology Advitech Inc. is a health sciences and technology company, which develops, manufactures and marketes proprietary natural ingredients and formulations for oral and topical applications. Its products are based on three technological platforms: a superior multi-functional emulsification delivery system derived from plant seed oleosomes for formulation application in the topical cosmetic, OTC, Rx and natural personal care specialty ingredient markets, XP-828L for immune mediated inflammatory disorders and IM for anti-aging and wound healing. Advitech was founded in 1997 and is headquartered in Québec, Canada | Health Technology |
CDP Capital Private Equity
CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Finance |
Emerillon Therapeutics, Inc.
Emerillon Therapeutics, Inc. BiotechnologyHealth Technology Emerillon Therapeutics, Inc. used to develop genomics-based drugs for human complex diseases through its unique RCS mouse platform technology, its access to human patient samples, and its expertise in high throughput mutation screening and ion channel genomics. It also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in January 2003 and is headquartered was Montréal, Canada. | Health Technology |
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
SOFINOV Société Financière d'Innovation, Inc.
SOFINOV Société Financière d'Innovation, Inc. Financial ConglomeratesFinance Sofinov, Societe Financiere d'Innovation, Inc. provides investment services. The firm assists new and expanding firms in key innovative sectors, including information technology, life sciences, and industrial goods, such as aeronautics and environmental technology. The company is headquartered in Montreal, Canada. | Finance |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Finance |
AgeChem Financial, Inc.
AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Finance |
Warnex, Inc.
Warnex, Inc. Medical SpecialtiesHealth Technology Warnex, Inc. engages as a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical sector. The company was founded on January 4, 1996 and is headquartered in Laval, Canada. | Health Technology |
The Caisse de dépôt et placement du Québec
The Caisse de dépôt et placement du Québec Investment ManagersFinance The Caisse de dépôt et placement du Québec (CDPQ) is a government-owned institutional fund manager headquartered in Montréal, Canada. Founded in 1965, CDPQ manages the funds of several depositor groups primarily for public and parapublic pension and insurance plans which pay out benefits to more than two million Quebecers each year. | Finance |
Conatus Pharmaceuticals, Inc.
Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Natunola AgriTech, Inc.
Natunola AgriTech, Inc. Pharmaceuticals: OtherHealth Technology Natunola AgriTech, Inc. develops, manufactures and markets proprietary natural ingredients. It offers ingredients to the personal care, food and nutraceutical markets. The company was founded on June 30, 2004 and is headquartered in Winchester, Canada. | Health Technology |
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada. | Health Technology |
Nuchem Therapeutics, Inc.
Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Commercial Services |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. |
- Stock Market
- Insiders
- Louis P. Lacasse
- Experience